The Food and Drug Administration is expected to significantly restrict the use of a pair of monoclonal antibody treatments for COVID-19 because they are ineffective against the omicron variant, a senior administration health official confirmed.As a…
Source: The Hill
FDA expected to restrict use of two COVID-19 monoclonal antibody treatments
More from Make America Late AgainMore posts in Make America Late Again »
- Psaki, Jean-Pierre absences give others possible at White House audition
- The Memo: Border surge spells trouble for Biden, DemocratsÂ
- 4 in 10 Americans blame Biden administration policies for gas prices: poll
- US says Putin feels 'misled' by Russian military
- White House rips Trump for urging Putin to release dirt on Hunter Biden
Be First to Comment